Healthcare
IFC, Sabre anchor HealthCare Global's India IPO
The International Finance Corporation (IFC), Sabre Partners and other anchor investors have committed INR2.92 billion ($43.6 million) to Indian cancer care services provider HeathCare Global Enterprises as part of its IPO.
Ping An leads $10m Series A for Hong Kong's Prenetics
Ping An Ventures, the VC arm of China's Ping An Insurance Group, has led a $10 million Series A round for Hong Kong-based genetic test developer Prenetics.
US PE firm leads $41m round for Japan's Takeda
US-based GP Frazier Healthcare Partners is leading a $41 million Series A round for Japanese medical research and development company Takeda Pharmaceutical.
Indian healthcare: Booster shots
Technological progress and changing consumer habits are bringing long-overdue change to India’s overworked healthcare system. Taking advantage will mean mastering the unique challenges of the market
Malaysia's VC-backed PurelyB buys Singapore yoga portal
Malaysian health and wellness company PurelyB has acquired Singaporean yoga lifestyle website Stretch City.
Warburg Pincus trims stake in China Biologic
Warburg Pincus has generated $425.7 million by selling an approximately 16% interest in US-listed biopharmaceuticals developer China Biologic Products.
Corporate VC in China healthcare: Formula for success
Despite the rapid growth of the Chinese pharmaceutical industry, corporate venture capital so far has not built a large presence. Industry participants say this shows the market, though booming, is still immature
Blue Sky-backed Alcidion lists in Australia
Blue Sky Alternative Investments-backed healthcare technology company Alcidion has listed in Australia with a A$2 million ($1.4 million) IPO priced at A$0.03 a share.
Eight Roads leads $8m round for Japan's Port
Eight Roads Ventures Japan has led a JPY900 million ($7.9 million) round of funding for Tokyo-based online content developer Port.
SAIF seeks $800m for China fund
SAIF Partners is targeting $800 million for its fifth Greater China fund, which will make growth investments in the technology, healthcare and cleantech sectors.
Australia services: Roll-up rapport
As Australia rebalances its economy in the wake of the commodities downturn, services are coming to the fore. Private equity investors continue to see consolidation opportunities
China's Impact Therapeutics get $10m Series B round
Existing backer Lilly Asia Ventures has been joined by new investors, including China Summit Capital, in a $10 million Series B round of funding for Impact Therapeutics, a China-based cancer drug developer.
IFC commits $25m to India's VC-backed Lenskart
The International Finance Corporation (IFC), the investment arm of the World Bank, has committed $25 million to Indian online eyewear retailer Lenskart.
J-Star targets buyout of JASDAQ-listed drugstore chain
J-Star has launched a tender offer for drugstore chain Aisei Pharmacy that values the JASDAQ-listed company at approximately JPY12.7 billion ($112.5 million). This is the private equity firm’s first-ever tender offer.
CICC, Chinese strategic launch competing offer for Sinovac
China-based Sinovac Biotech, which earlier this week became the target of a take-private bid from its chairman and SAIF Partners, has received a competing offer from a consortium that includes China International Capital Corporation (CICC).
PE-backed BeiGene gains 18% on debut after $158m IPO
BeiGene, a Chinese cancer drug developer backed by Hillhouse Capital and CITIC Private Equity, closed up 18% on its first day of trading on NASDAQ following a $158.4 million IPO.
SAIF backs chairman's $345m bid for US-listed Sinovac
SAIF Partners has teamed up with the chairman and CEO of Chinese biopharmaceutical player Sinovac Biotech to submit a $345 million buyout offer for the NASDAQ-listed company.
ADV commits $45m to Indian hospital chain, Invascent exits
ADV Partners has invested $45 million in Indian hospital chain Dr. Agarwal's Healthcare, providing an exit for existing backer Invascent Capital.
VC-backed China healthcare platform raises $20m
We Doctor Group, a Chinese online healthcare information portal formerly known as Guahao.com, has raised a further $20 million from Shanghai-listed property developer Shandong Tyan Home.
China's Adagene raises $28m
Adagene, a China-based life sciences company focused on smart antibody technology, has raised a $28 million Series B round led by GP Healthcare Capital, the medical-focused subsidiary of China's GP Capital.
KTB, Jolly Innovation lead $30m round for China's CARsgen
KTB Ventures and Jolly Innovation Ventures have led a $30 million Series B round for Shanghai-based cancer therapy developer CARsgen Therapeutics.
Qiming closes fifth China VC fund at $648m – update
Qiming Venture Partners has announced that it has closed its fifth US dollar-denominated China VC fund at $648 million.
Deal focus: Abraaj builds on India healthcare foundation
The Abraaj Group buys India's CARE Hospitals from Advent International with a view to taking the business into new markets
China Cocoon Network launches $720m European tech fund
London-based Cocoon Networks, which is backed private equity firms China Equity Group and Hanxin Capital, has launched a GBP500 million ($720 million) venture fund to invest in UK and European technology start-ups.